Why Do Some Women Get Breast Implant Illness While Others Don't?

July 8, 2026

Why Do Some Women Get Breast Implant Illness While Others Don't?


(Based on a recent interview with Dabney Poorter, NP and Dr. Brighton Miller, DO discussing breast implant illness with Dr. Robert Whitfield)


---


Two women can have the same implant, placed the same year, by different surgeons in different cities, and end up in completely different places. One feels fine for a decade. The other develops fatigue, joint pain, brain fog, and a rash that will not clear no matter what a dermatologist tries. Why?


That question sat at the center of a recent conversation between Dabney Poorter, a nurse practitioner and owner of Restore and Revive, a functional medicine practice in Fort Worth, Dr. Brighton Miller, a board-certified family medicine physician who has her own history with autoimmune disease and breast implant illness (BII), and Dr. Robert Whitfield, a board-certified plastic surgeon in Austin, Texas. Their discussion moved through Dr. Whitfield's surgical background, what current research shows about bacteria inside implant capsules, and why genetics and toxic burden appear to explain a lot of the variation patients experience.


A Surgeon's Path Into Breast Implant Illness


Dr. Whitfield trained in general surgery from 1996 to 2002, before work hour restrictions existed for residents, followed by a plastic surgery residency and a one year microsurgery fellowship. For the first fifteen years of his career, his focus was reconstructive microsurgery, particularly DIEP flap reconstruction for breast cancer patients, along with head and neck and sarcoma reconstruction.


That background matters for this conversation because it shaped how he thinks about implants. As he put it, anyone treating cancer reconstruction patients develops "a very, very healthy respect for any device," because a device that becomes infected in an immunosuppressed chemotherapy patient is a same-day surgical emergency, not something to watch and wait on.


A single case in 2016 changed the direction of his career. A breast cancer patient asked him to remove her implant and capsule intact rather than the complete capsulectomy he had always performed. Following his standard practice, he sent the tissue for culture, pathology, and infection testing. The pathology came back clear of cancer, but the culture identified a significant occult E. coli infection, in a patient whose only symptom had been fatigue, something easy to attribute to chemotherapy alone. That case led him to ask how many other patients with implant-related symptoms had been quietly living with an infection that nobody tested for.


What Actually Happens Inside a Capsule


The scar tissue that forms around any implant is often assumed to be a solid, impermeable barrier. It is not. It behaves more like a woven layer that allows cellular signaling to pass through it, which is part of why some patients experience symptoms that seem disconnected from the implant itself.


The Research Behind the Findings


Dr. Whitfield and his team have published PCR testing results on nearly 700 consecutive capsule tissue samples, described as the largest PCR-tested explant capsule series published to date. That research found bacterial contamination in roughly 29 percent of tested capsules, a rate not reliably detected using standard culture methods alone. Standard cultures can miss low-level biofilm colonies that PCR technology is more likely to identify.


How the Body May Respond to a Foreign Device


Beyond infection, there appears to be a separate immune question. Recent research out of Denmark, referenced in the conversation, describes patterns in some patients that resemble aspects of tissue rejection, including T-cell activity, occasional B-cell lymphoma (a rare complication linked to certain textured implant surfaces), and elevated plasma cell activity suggestive of antibody production. This is different from the more expected foreign body response, which typically involves giant cells and chronic, low-grade inflammation. Dr. Whitfield was careful to frame this as an area of active research rather than a settled, universal mechanism, and emphasized that not every patient experiences this response in the same way.


Where does bacteria like this come from in the first place? Dr. Whitfield raised one theory worth considering: certain organisms associated with breast infections, including a bacterium commonly linked to pool and hot tub exposure, may colonize breast tissue years before an implant is ever placed, particularly in patients who spent significant time swimming as children. This does not mean every case traces back to a childhood pool, but it illustrates how a capsule infection can have origins that predate the implant itself by decades, which is part of why routine post-operative screening alone may not catch every case.


Why Genetics and Toxic Burden Change the Picture


This is the part of the conversation that may explain why implant experiences vary so much from one patient to the next. Based on genetic testing across his patient population, Dr. Whitfield reports that a large majority show variants in antioxidant support pathways, including glutathione and glucuronidation pathways the body relies on to help process everyday chemical exposures. A well known example is the MTHFR variant, present in roughly a third of the general population, but he also pointed to vitamin D pathway variants (including GPX and VDR) as an underappreciated factor connected to both bone health and broader inflammation.


Genetics is only part of the equation. Toxic burden, the cumulative load of environmental exposures a person has accumulated over a lifetime, also appears to matter. In the conversation, Dr. Whitfield described asking detailed questions about where patients grew up, what kind of work they did, whether they lived somewhere with mold exposure, and their travel history. A person with a strong genetic capacity to clear toxins may coexist with an implant for years without symptoms. A person carrying a heavier toxic burden, alongside genetic variants that limit detoxification capacity, may reach a tipping point sooner. As he summarized it, resilience, not the mere presence of an implant, appears to be the deciding factor for many patients. For readers who want to understand more about how these symptom patterns are evaluated, the BII hub page at https://drrobertwhitfield.com/breast-implant-illness walks through the broader picture in more depth.


Why Capsular Contracture Rates Changed, Not Disappeared


It is worth understanding a piece of implant history before assuming newer devices have solved older problems. The Baker grading scale, used to assess capsular contracture (firmness and pain around an implant), dates back to 1975. Reported contracture rates dropped in the decades that followed, but Dr. Whitfield offered a different explanation than simply "better devices": placement shifted from above the muscle to below it, which may have made the same underlying problem physically harder to feel and report, rather than resolving the problem itself.


This distinction matters for anyone evaluating newer implant technology, including devices marketed as lower-friction or less stimulating to surrounding tissue. Any device placed in the body carries some risk of infection, biofilm formation, or a firm, uncomfortable capsule forming around it. Dr. Whitfield noted he has already removed several of the newest-generation devices from symptomatic patients, a reminder that newer marketing claims do not automatically mean lower risk.


How the SHARP Framework Applies to This Discussion


Much of what Dr. Whitfield described lines up directly with the SHARP framework (Strategic Holistic Accelerated Recovery Program), which is built around preparing the body before surgery rather than only addressing problems afterward.


Sleep surfaced repeatedly as a foundational piece. Disrupted sleep, including undiagnosed obstructive sleep apnea, was described as a common and under-recognized issue, particularly because women with sleep apnea often do not snore in the way many people expect. Getting seven to nine hours of consistent sleep, limiting fluids before bed, and getting daylight exposure in the morning were all mentioned as practical starting points.


Protein intake and nutrition were emphasized just as strongly. After surgery, the body needs enough amino acids to move out of what Dr. Whitfield called a "negative nitrogen balance," which affects how tissue heals and how much swelling a patient experiences during recovery. He generally recommends 100 to 150 grams of protein daily for patients preparing for or recovering from surgery, alongside healthy fats and a focus on maintaining, not losing, lean muscle mass.


Recovery tools mentioned in the conversation included soft-sided hyperbaric oxygen therapy to support oxygen delivery to healing tissue, lymphatic massage devices to help move fluid more efficiently after surgery, red light therapy, and nervous system support tools intended to help patients shift out of a high-cortisol state more quickly. None of these were described as guarantees of a particular outcome. They were framed as ways to support the body's own healing capacity alongside surgery.


Vitamin D pathway support was highlighted specifically, with liposomal D3/K2 supplementation mentioned as the general approach for patients showing relevant genetic variants, rather than a one-size-fits-all recommendation. Patients preparing for any implant-related procedure can find products built around this preparation window at https://drrobssolutions.com/products/inflammation-support-bundle, and those wanting to understand their own toxic burden before making a decision can start with https://www.drrobssolutions.com/products/total-tox-burden-test.


A few simple daily habits also came up. Mineral sunscreen and sun avoidance over new scars were mentioned as important, since UV exposure can worsen scar pigmentation during the first year of healing. Sleep tracking with a wearable device was described as a useful way to gauge whether recovery habits are actually working, rather than guessing. If you are unsure whether your symptoms warrant a closer look, booking a discovery call at https://discovery.drrobertwhitfield.com/form is a reasonable next step before deciding on any procedure.


What This Means If You're Considering Explant or Fat Transfer


A few practical points came up that are worth understanding before pursuing either procedure.


Capsulectomy matters. Removing an implant without removing the surrounding capsule can leave behind material embedded in scar tissue, which may allow symptoms to persist. Dr. Whitfield described a case where a ruptured implant was removed under local anesthesia without any capsule removal, and the patient's symptoms did not resolve, because the debris causing the reaction was still present in the tissue.


Fat transfer candidacy is not primarily about body mass index. Dr. Whitfield uses a DEXA scan, rather than visual assessment or standard BMI cutoffs, to evaluate a patient's body composition before recommending a fat transfer approach. He also flagged GLP-1 agonist medications as a significant complicating factor, since they are designed to reduce fat stores, which works directly against the goal of a successful fat graft.


"Overgrafting," the practice of injecting more fat than tissue can reasonably support, was raised as a serious concern. Dr. Whitfield was direct that this can create lumps or fat necrosis that may be mistaken for cancer recurrence in reconstruction patients, and he described this practice as one he considers unethical when used to compensate for inexperience.


Frequently Asked Questions


What is breast implant illness?

Breast implant illness (BII) is a term patients and some clinicians use to describe a cluster of symptoms, including fatigue, joint and muscle pain, brain fog, gut issues, and skin changes, that some patients report developing after receiving breast implants. It is not yet a single, universally defined medical diagnosis, and research into its underlying mechanisms is ongoing.


Why do some women get breast implant illness and others don't?

Based on the genetic and toxicity patterns discussed in this interview, resilience appears to play a meaningful role. Genetic variants affecting antioxidant and detoxification pathways, combined with a person's cumulative toxic burden from environmental exposures, may influence whether and when symptoms develop.


Can bacteria really live inside a breast implant capsule without causing an obvious infection?

Published PCR testing on nearly 700 capsule samples found bacterial contamination in about 29 percent of cases, a rate that standard culture testing alone often misses. This does not mean every capsule is contaminated, but it does suggest standard testing may underestimate how common low-level bacterial presence can be.


Is a capsulectomy always necessary during explant surgery?

Not automatically, but leaving behind capsule material that contains embedded debris from a ruptured or worn implant shell may allow symptoms to continue. Discussing capsulectomy specifically with a surgeon experienced in implant-related complications is an important part of the conversation before surgery.


What can I do before surgery to prepare my body?

The SHARP framework emphasizes sleep quality (including screening for sleep apnea), adequate protein intake, and addressing known genetic or toxicity factors well before a procedure. These steps are described as supportive of recovery, not as guarantees of a specific outcome.


Does having breast implants mean I will eventually develop autoimmune symptoms?

No. Many patients coexist with implants without symptoms for years. The conversation emphasized that resilience, genetics, and cumulative toxic burden appear to shape individual risk, rather than implants themselves being universally symptomatic.


Disclaimer: The content provided in this article is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any changes to your health regimen, supplements, or treatment plan. Results discussed are not guaranteed and individual outcomes will vary.


Take the Next Step


Take a free health assessment now:

https://www.drrobertwhitfield.com/sharp


Download your free inflammation support guide:

https://www.drrobssolutions.com/products/free-inflammation-support-guide


Book a discovery call now:

https://discovery.drrobertwhitfield.com/form


Check out Dr. Robert Whitfield's favorite supplements and labs:

https://drrobssolutions.com/products/inflammation-support-bundle